Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS: NWBO · Delayed Price · USD
0.388
0.00 (0.08%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Northwest Biotherapeutics Employees
Northwest Biotherapeutics had 25 employees as of December 31, 2023. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
$53,440
Profits / Employee
-$2,831,120
Market Cap
469.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
NWBO News
- 18 days ago - Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities - PRNewsWire
- 4 weeks ago - Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property - PRNewsWire
- 4 months ago - Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors - PRNewsWire
- 5 months ago - Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification - PRNewsWire
- 7 months ago - Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma - PRNewsWire
- 8 months ago - Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application - PRNewsWire
- 10 months ago - Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application - PRNewsWire
- 11 months ago - Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board - PRNewsWire